Description

Precision manufacturing of medical devices, digital health solutions and innovative therapeutics will be backed with up to $1.5 billion in public funding under the first guidance for a priority sector by the Albanese government. The Medical Science Co-investment Plan released Monday by Industry and Science minister Ed Husic touts an opportunity to build industrial capacity and capability in areas of national advantage by partnering with private investors. It rules out supporting high-volume, low-value medicines in a revitalisation of Australian manufacturing pledged more than two years ago by the government, instead saying the support must target high-value, innovative, complex therapeutics, devices and cutting-edge digital health solutions.

Summary

The Australian government has introduced a new plan under the leadership of Industry and Science Minister Ed Husic, which allocates up to $1.5 billion for precision manufacturing in the medical sector. The initiative focuses on boosting industrial capabilities by supporting innovative therapeutics, medical devices, and digital health solutions, emphasizing high-value contributions over high-volume, low-value products. This development underlines the Albanese government's commitment to revitalizing Australia's manufacturing sector, particularly in domains of national competitive advantage. While the plan primarily addresses medical manufacturing, the approach and frameworks developed could have implications for broader AI safety policy, especially in how emerging technologies are governed in high-stakes industries.

Body